| Product Name | MF | CAS | Details |
|---|
| CEP350 antibody | Details |
| Longipedlactone J | C32H40O7 | 1011762-93-8 | Details |
| 4-Chloro-N-[3-(dimethylamino)propyl]-3-nitrobenzene-1-sulfonamide | C11H16ClN3O4S | 53803-81-9 | Details |
| 2-(4-(benzo[d]1,3-dioxolan-5-ylmethyl)piperazinyl)-N-(2,5-dimethoxyphenyl)ethanamide | C22H27N3O5 | 484027-74-9 | Details |
| 2-Cyclohexyl-N-(1,2,3,4-tetrahydroquinolin-5-yl)acetamide | C17H24N2O | 1042653-47-3 | Details |
| 2-Bromo-5,6-dimethylnicotinonitrile | C8H7BrN2 | 113124-06-4 | Details |
| Methyl 7-hydroxy-2-naphthoate | C12H10O3 | 95901-05-6 | Details |
| MCM5 Blocking Peptide | Details |
| H-Tyr-Trp-OH | C20H21N3O4 | 60815-41-0 | Details |
| Cilengitide | C27H40N8O7 | 188968-51-6 | Details |
| [(3-Ethyl-1,2-oxazol-4-yl)methyl](methyl)amine | C7H12N2O | 1512204-67-9 | Details |
| Dimethyl 5-[(2-chloropropanoyl)amino]isophthalate | C13H14ClNO5 | 956576-41-3 | Details |
| 1,2-Bis(3-fluorophenyl)ethan-1-amine | C14H13F2N | 1183075-90-2 | Details |
| Obtusafuran methyl ether | C17H18O3 | 40357-59-3 | Details |
| Dapagliflozin Impurity 17 | C15H14Br2O | 1807632-93-4 | Details |
| (Cyclobutylmethyl)[(2,4-dimethoxyphenyl)methyl]amine | C14H21NO2 | 1096278-17-9 | Details |
| 2-(2-Aminobutan-2-yl)-6-ethyl-3,4-dihydropyrimidin-4-one hydrochloride | C10H18ClN3O | 1333944-77-6 | Details |
| 1-(2-Aminophenyl)-1H-pyrazole | C9H9N3 | 54705-91-8 | Details |
| (1S)-1-(Thiophen-2-yl)propan-1-amine hydrochloride | C7H12ClNS | 1807933-93-2 | Details |
| 16:0-18:2 PC | C42H80NO8P | 159701-21-0 | Details |
| 1-Bromo-3-chloro-5-fluoro-2-iodobenzene | C6H2BrClFI | 1000577-66-1 | Details |
| Ethyl 4-oxo-4-(thiophen-2-yl)butanoate | C10H12O3S | 59086-25-8 | Details |
| 3-(1H-Pyrazol-4-yl)piperidine | C8H13N3 | 1211515-46-6 | Details |
| 3-Methyl-octahydropyrrolo[1,2-a]piperazin-4-one | C8H14N2O | 1822529-02-1 | Details |
| Brinzolamide | C12H21N3O5S3 | 138890-62-7 | Details |
| Ethyl 2-(4-cyano-1H-imidazol-1-yl)acetate | C8H9N3O2 | 1154030-58-6 | Details |
| 7-Bromo-2-(chloromethyl)quinazolin-4-ol | C9H6BrClN2O | 573681-17-1 | Details |
| APBB2 antibody | Details |
| 5-Methylcytosine | C5H7N3O | 554-01-8 | Details |
| GIP protein (His tag) | Details |
| Hyaluronic acid from Bacteria | C14H22NNaO11 | 9004-61-9 | Details |
| 5-Chloro-8-fluoro-1,2,3,4-tetrahydroisoquinoline | C9H9ClFN | 924307-81-3 | Details |
| Anti PHI (Rat) Serum | Details |
| (2S,4R)-4-Methoxypyrrolidine-2-carboxylic acid | C6H11NO3 | 75176-09-9 | Details |
| 2,6-Dichloro-3-nitrobenzonitrile | C7H2Cl2N2O2 | 5866-98-8 | Details |
| Elesclomol | C19H20N4O2S2 | 488832-69-5 | Details |
| 4-Bromobenzaldehyde oxime | C7H6BrNO | 34158-73-1 | Details |
| LX-4 | C29H19N5O4S2 | 340691-65-8 | Details |
| Pararosaniline base | C19H19N3O | 467-62-9 | Details |
| Free hCG Beta recombinant antibody | Details |
| Mesitylacetonitrile | C11H13N | 34688-71-6 | Details |
| 5-(3-Bromophenyl)-2-(chloromethyl)-1,3-oxazole | C10H7BrClNO | 1094382-35-0 | Details |
| 2-(2,5-Dimethylphenyl)-1H-indole-3-carbaldehyde | C17H15NO | 590391-00-7 | Details |
| H-MMNDQLMFL-OH | Details |
| Formyl-MLF-[Cys(AF488)] | Details |
| 4-Aminobenzoic acid | C7H7NO2 | 150-13-0 | Details |
| 2-Phenylmethanesulfinylethan-1-amine | C9H13NOS | 30491-32-8 | Details |
| RTC13 | C14H9N3O4S | 1359825-94-7 | Details |
| 5-Cyclopropyl-1-methyl-pyrazole-3-carboxylic acid | C8H10N2O2 | 1177291-38-1 | Details |
| (3-Trifluoromethylpyrid-2-yl)hydrazine | C6H6F3N3 | 89570-83-2 | Details |
| 4-[(Butan-2-yl)amino]benzamide | C11H16N2O | 1019497-02-9 | Details |
| N-Cyclobutyl-4-methylaniline | C11H15N | 170303-48-7 | Details |
| 1-[(3,5-Dimethyl-1H-pyrazol-4-yl)sulfonyl]piperidine-4-carboxylic acid | C11H17N3O4S | 1023930-69-9 | Details |
| 2-{1-[4-(Trifluoromethyl)phenyl]cyclobutyl}acetic acid | C13H13F3O2 | 1358805-32-9 | Details |
| Methyl[(1-methyl-1H-pyrazol-5-yl)methyl]amine hydrochloride | C6H12ClN3 | 1788989-09-2 | Details |
| 1-(3-Methylmorpholin-4-yl)propan-2-amine | C8H18N2O | 1215927-36-8 | Details |
| N-[2-(Dimethylamino)ethyl]piperidine-4-carboxamide dihydrochloride | C10H22ClN3O | 1019851-96-7 | Details |
| 3-[3-(Difluoromethoxy)phenyl]propionic acid | C10H10F2O3 | 1092460-66-6 | Details |
| 6-Amino-2,5-dimethylpyrimidin-4-ol | C6H9N3O | 14278-61-6 | Details |
| 3-Bromo-4-(piperidin-1-yl)benzaldehyde | C12H14BrNO | 946749-04-8 | Details |
| Rock2 (5-554), active, His tagged human | 182938-08-5 | Details |
| (S)-tert-Butyl 2-acetylpyrrolidine-1-carboxylate | C11H19NO3 | 91550-08-2 | Details |
| 1-Deoxy-L-mannitol | C6H14O5 | 488-28-8 | Details |
| Met antibody (Tyr1349) | Details |
| Sodium 2-(hydroxymethyl)benzene-1-sulfonate | C7H7NaO4S | 31910-67-5 | Details |
| 4-(Azetidin-3-yl)-4H-1,2,4-triazole dihydrochloride | C5H9ClN4 | 2375262-06-7 | Details |
| Ptdins-(1,2-dipalmitoyl) | C41H79O13P | 28366-80-5 | Details |
| 8-Nonen-1-ol | C9H18O | 13038-21-6 | Details |
| 3,4-Dihydro-1H-2-benzothiopyran-4-ol | C9H10OS | 109819-33-2 | Details |
| Dog Albumin Reference Serum | Details |
| 2-(Pyrrolidin-3-yl)acetonitrile hydrochloride | C6H11ClN2 | 152400-87-8 | Details |
| D-Fructose-1,6-diphosphate tetra(cyclohexylammonium) salt | C30H66N4O12P2 | 56594-87-7 | Details |
| 1,4-Bis[(tert-butoxy)carbonyl]piperidine-4-carboxylic acid | C16H27NO6 | 1955524-38-5 | Details |
| [D-Ala2,D-Leu5]-Enkephalin | C31H43N5O9 | 94825-57-7 | Details |
| 2-Methoxycarbonylphenyl β-D-glucopyranoside | C14H18O8 | 10019-60-0 | Details |
| rac-[(3R,4R)-4-(Hydroxymethyl)pyrrolidin-3-yl]methanol hydrochloride | C6H14ClNO2 | 1609409-08-6 | Details |
| 5-Sulfamoylthiophene-2-carboxylic acid | C5H5NO4S2 | 7353-87-9 | Details |
| 1-[(Pyrrolidin-3-yl)methyl]imidazolidin-2-one | C8H15N3O | 1510803-57-2 | Details |
| 4-Methylthiazole-2-carbonitrile | C5H4N2S | 100516-98-1 | Details |
| 4-Chloro-2-methyl-8-(trifluoromethoxy)quinoline | C11H7ClF3NO | 927800-56-4 | Details |
| 3-(methoxycarbonyl)cyclohexane-1-carboxylic acid, Mixture of diastereomers | C9H14O4 | 25090-39-5 | Details |
| 1-Methyl-5-(trifluoromethyl)-1H-1,2,3-triazole-4-carboxylic acid | C5H4F3N3O2 | 1266841-66-0 | Details |
| 1,6-Hexylenediphosphonic Acid | C6H16O6P2 | 4721-22-6 | Details |
| 3-(1-{[(9H-Fluoren-9-yl)methoxy]carbonyl}piperidin-4-yl)-1,2-oxazole-4-carboxylic acid | C24H22N2O5 | 2260931-59-5 | Details |
| Anthrose | C12H23NO6 | 769959-88-8 | Details |
| Buforin II | C106H184N40O26 | 172998-24-2 | Details |
| Dezapelisib | C20H16FN7OS | 1262440-25-4 | Details |
| 3-[(Thiophene-2-sulfonamido)methyl]benzoic acid | C12H11NO4S2 | 886732-79-2 | Details |
| (2-Bromo-1-ethoxyethyl)cyclopropane | C7H13BrO | 1086271-38-6 | Details |
| C9ORF153 antibody | Details |
| CBG antibody | Details |
| 2-(4-Ethylpiperazin-1-yl)-6H,7H-[1,3]thiazolo[4,5-d]pyrimidin-7-one | C11H15N5OS | 1255783-47-1 | Details |
| Lyme Disease (Borrelia) Antibody Negative CSF | Details |
| RNF182 Blocking Peptide | Details |
| H-IRFRFDGQPI-OH | Details |
| TOLLIP Blocking Peptide | Details |
| 2,6-Dimethylheptan-4-amine hydrochloride | C9H22ClN | 130996-65-5 | Details |
| 3-((3,5-difluorophenyl)amino)-2-((4-chlorophenyl)sulfonyl)prop-2-enenitrile | C15H9ClF2N2O2S | 1025174-31-5 | Details |
| 1,3,6-Tri-O-acetyl-3-O-(2,3,4,6-tetra-O-acetyl-b-D-galactopyranosyl)-2-azido-2-deoxy-a-D-glucopyranose | C26H36N3O17 | Details |
| 5-(Piperidine-1-sulfonyl)furan-2-carboxylic acid | C10H13NO5S | 933735-49-0 | Details |
| Product Total： Product Page： | ||||
| 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 | ||||